Hide Board Information

Show Board Information

Aquestive Therapeutics Inc. AQST

Board Mod: Add me as mod

Asst Mods:

Last Post: 08/12/2022 4:48:36 PM

Board Marks: 1

Posts Today: 0

Board Views Today: 3

Aquestive Therapeutics Inc. (NASDAQ: AQST) Stock Message Board

1. AQST Company Profile

    

2. AQST Time & Sales

    

3. AQST Recent News

    

4. AQST Filings

    

5. AQST Financials

    

6. AQST Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

8	AQST 24% v2,2M c1.73 f53,4M H1.78 ML.78 LL.62	znewcar1	08/12/2022 4:48:36 PM
7	AQSRI - Price Drop	J L	12/21/2021 2:52:42 PM
6	AQST - Monday Rundown, Tuesday Expectations	J L	12/20/2021 11:43:00 PM
5	AQST - FDA Approval Insight	J L	12/19/2021 3:40:09 PM
4	AQST - Tuesday Rundown, Wednesday Expectations	J L	11/30/2021 11:28:53 PM
3	AQST - Update	J L	10/15/2021 3:06:04 PM
2	AQST - Tuesday Rundown, Wednesday Expectations	J L	09/07/2021 11:45:19 PM
1	Look like target to $8-$10 after	Tomboston	05/16/2020 4:09:52 PM

Recent Articles

• Investors Have Opportunity to Lead Xerox Holdings Class Action
• Important Class Action Update for WM Technology Investors
• Investors Alert: Join the TMC Class Action Now Before Deadline
• Central 1 Credit Union’s Q3 2024 Performance Update
• Navigating Trade Tensions: How Chinese Firms Manage Currency Risks
• Chipotle Investors Urged to Act Ahead of Securities Deadline
• Lumina Gold Secures Extended Mining Concession Until 2049
• Investors Encouraged to Act Before Midnight Hub's Deadline
• Understanding the Toronto-Dominion Bank Class Action Lawsuit
• Leadership Changes at River Valley Community Bancorp Announced
• Germany's Medical Cannabis Surge: Market Growth and Potential
• Aleut Environmental Secures $48M Contract for Government Services
• Leadership Transition at Carbon Streaming: Marin Katusa Steps Up
• NASA Contracts Sierra Lobo for Test Operations at Stennis
• Brookfield Residential Partners with Kolter for Growth in Land Development
• Intouch Insight Reports Impressive Q3 2024 Earnings Growth
• FAA Lifts Flight Restrictions to Northern Haiti Airports
• Exciting Space-Themed Event with Astronaut Dr. Sian Proctor
• MicroStrategy's Strategic Moves Spark After-Hours Stock Surge
• Porsche Taycan Turbo GT Triumphs at Performance EV Awards
• Analyzing the Impact of Geopolitical Events on Crude Oil WTI
• Stellar Bancorp Ups Dividend as Financial Confidence Grows
• NVIDIA Prepares for Key Events to Engage Financial Audience
• Timbercreek Financial Announces Monthly Dividend and Plan
• Hanwha Life Strengthens US Presence with Strategic Acquisition
• Denmark's Trailblazing Steps Towards Medical Cannabis Permanence
• Cryptocurrency Market Surges: Bitcoin Eyes $100K Milestone
• North American Construction Group Secures Major Oil Sands Project
• Vote for New Board Members to Drive NexPoint Forward
• Cannabis Sector Reacts as Political Drama Unfolds
• Class A Multifamily Rent Growth: A Bright Future Ahead
• Investors of Lilium N.V. Can Join Securities Class Action Now
• Grey Wolf Animal Health Shows Strong Q3 Growth in 2024
• Gentherm Welcomes New CFO to Enhance Financial Strategy
• David Goodin Joins NorthWestern Energy Board as Strategic Asset
• Cheche Group Faces Nasdaq Compliance Challenge Amid Growth
• Orion Group Holdings Expands Portfolio with New Major Contracts
• Zevra Therapeutics Launches MIPLYFFA for Niemann-Pick Disease
• Yum! Brands Announces Quarterly Dividend and Financial Highlights
• Japan's Inflation and Market Dynamics: A Deep Dive Analysis
• Ross Stores Ups Annual Profit Outlook Amid Market Challenges
• TeraWulf Elevates Sean Farrell to COO, Strengthening Operations
• NXP Semiconductors Declares Upcoming Dividend Payments
• Capital City Bank Group Declares Quarterly Cash Dividend Announcement
• WEBTOON Entertainment's Upcoming Conferences: What to Expect
• NetApp Reports Impressive Q2 Financial Performance Insights
• Gap, Inc. Impresses with Robust Q3 Earnings and Guidance Boost
• BioXcel Therapeutics Launches Exciting Stock Offering Strategy
• CV Sciences Deepens Market Presence with Extract Labs Acquisition
• Small-Cap Stocks Shine in November: December Opportunities Ahead